Boston Scientific Corp. grew its headcount by 5,000 and its real estate footprint by more than 1 million square feet in 2024.
If we fail to scale manufacturing in the United States, then our best bio-innovations will be brewed in China.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback